News

A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...
WHO includes ArkBio' paediatric RSV drug, ziresovir in PADO-RSV priority list: Shanghai, China Thursday, July 17, 2025, 14:00 Hrs [IST] Shanghai Ark Biopharmaceutical Co., Ltd. (A ...
Some patients with highly drug-resistant tuberculosis could benefit from a shorter treatment with fewer drugs, while others ...
Testing at India’s National Institute of Virology has confirmed a third recent Nipah virus case from India’s Kerla state, ...
SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...
The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...
RSV has outstripped severe Covid and flu hospitalisation rates and proved itself more fatal than either of the flu season ...